Dr. Mathew Upton PhD.

Current affiliation:
Senior Lecturer in Medical Microbiology, School of Medicine, University of Manchester, UK
Affiliation from May 2013 - Reader in Medical Microbiology, School of Biological and Biomedical Sciences, University of Plymouth, UK

Recent publications:

  • Sandiford, SK & M. Upton. (2012). Identification, characterisation and recombinant expression of epidermicin NI01, a potent unmodified bacteriocin produced by Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy, 56(3).
  • Upton, M., P. Cotter & J.R. Tagg. (2012). Antimicrobial Peptides as Therapeutic Agents. International Journal of Microbiology, in press
  • Wescombe, P. A., M. Upton, P. Renault, R. E. Wirawan, D. Power, J. P. Burton, C. N. Chilcott and J. R. Tagg. (2011). Salivaricin 9 a new lantibiotic produced by Streptococcus salivarius. Microbiology 157:1290-9.
  • Al-Mahrous, Mohammed; Jack, Ralph; Sandiford, Stephanie; Tagg, John; Beatson, Scott; Upton, Mathew. (2011). Identification of a haemolysin-like peptide with antibacterial activity using the draft genome sequence of S. epidermidis strain A487. FEMS Immunology & Medical Microbiology, 62:273-82

Expertise and research areas:
medical microbiology

We would like to thanks all sponsors and partners!